Hormonal changes after localized prostate cancer treatment. Comparison between external beam radiation therapy and radical prostatectomy

Miller, 1998, Influence of radical prostatectomy on serum hormonal levels, J Urol, 160, 449, 10.1016/S0022-5347(01)62922-7 Olsson, 2010, Radical prostatectomy: influence on serum and urinary androgen levels, Prostate, 70, 200 Lackner, 2008, Serum inhibin–not a cause of low testosterone levels in hypogonadal prostate cancer?, Urology, 72, 1121, 10.1016/j.urology.2008.01.066 Madersbacher, 2002, Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis, Urology, 60, 869, 10.1016/S0090-4295(02)01893-9 Gacci, 2013, Changes in sex hormone levels after radical prostatectomy: results of a longitudinal cohort study, Oncol Lett, 6, 529, 10.3892/ol.2013.1420 Zagars, 1997, Serum testosterone levels after external beam radiation for clinically localized prostate cancer, Int J Radiat Oncol Biol Phys, 39, 85, 10.1016/S0360-3016(97)00311-8 Segal, 2009, Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer, J Clin Oncol, 27, 344, 10.1200/JCO.2007.15.4963 Pickles, 2002, What happens to testosterone after prostate radiation monotherapy and does it matter?, J Urol, 167, 2448, 10.1016/S0022-5347(05)65002-1 Tomic, 1983, Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone: follicle-stimulating hormone, luteinizing hormone and prolactin, J Urol, 130, 287, 10.1016/S0022-5347(17)51110-6 Oermann, 2011, Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low-to intermediate-risk prostate cancer, J Hematol Oncol, 4, 12, 10.1186/1756-8722-4-12 Daniell, 2001, Hypogonadism following prostate-bed radiation therapy for prostate carcinoma, Cancer, 91, 1889, 10.1002/1097-0142(20010515)91:10<1889::AID-CNCR1211>3.0.CO;2-U Reyes, 2012, The hypoxic testicle: physiology and pathophysiology, Oxid Med Cell Longev, 929285 Lokeshwar, 1993, Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma: the Dunning R3327G rat tumor, Cancer Res, 53, 4855 Risbridger, 1996, Inhibin-related proteins in rat prostate, J Endocr, 149, 93, 10.1677/joe.0.1490093 Ying, 1997, Expression and localization of inhibin/activin subunits and activin receptors in the normal rat prostate, Life Sci, 60, 397, 10.1016/S0024-3205(96)00664-9 Boehmer, 2005, Testicular dose in prostate cancer radiotherapy: Impact on impairment of fertility and hormonal function, Strahlenther Onkol, 181, 179, 10.1007/s00066-005-1282-1 D’Amico, 1995, A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer, J Urol, 154, 131, 10.1016/S0022-5347(01)67248-3 Sasagawa, 1993, Effect of transurethral resection of prostate on plasma hormone levels in benign prostatic hyperplasia, Br J Urol, 72, 611, 10.1111/j.1464-410X.1993.tb16219.x Türkölmez, 1998, Effects of transurethral prostate resection and transurethral laser prostatectomy on plasma hormone levels, Urol Int, 61, 162, 10.1159/000030314 Seal, 1979, FSH and LH elevation after radiation for treatment of cancer of the prostate, Invest Urol, 16, 278 Grisby, 1986, The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate, J Urol, 135, 726, 10.1016/S0022-5347(17)45831-9 Schatzl, 2001, High-grade prostate cancer is associated with low serum testosterone levels, Prostate, 47, 52, 10.1002/pros.1046 Gacci, 2009, Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy, Health Qual Life Outcomes, 7, 94, 10.1186/1477-7525-7-94